Kalaris Therapeutics's total assets for Q4 2023 were $3.33M, a decrease of -98.66% from the previous quarter. KLRS total liabilities were $48.35M for the fiscal quarter, a -8.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.